What is Lutgen Technologies?
Lutgen Technologies, Inc. operates as a critical player in the life sciences supply chain, specializing in the engineering and manufacturing of high-quality freezer racks and cryogenic containment canisters. With a legacy spanning over two decades, the firm provides essential infrastructure for the secure storage of sensitive biological materials, including stem cells and bone marrow. Their comprehensive product portfolio—ranging from liquid nitrogen storage systems to sophisticated inventory control software—is engineered to meet the rigorous standards of medical research facilities and clinical laboratories. By maintaining a focus on American-made quality and ergonomic design, the company has established itself as a reliable partner for institutions requiring high-density, efficient storage solutions that prioritize sample integrity and operational ease.
How much funding has Lutgen Technologies raised?
Lutgen Technologies has raised a total of $72K across 1 funding round:
Debt
$72K
Debt (2021): $72K with participation from PPP
Key Investors in Lutgen Technologies
PPP
Public-Private Partnership
What's next for Lutgen Technologies?
With the recent influx of capital, Lutgen Technologies is poised to transition into a more aggressive growth phase, likely focusing on the modernization of its manufacturing facilities and the expansion of its inventory management software suite. The company is expected to prioritize R&D initiatives that address the increasing complexity of biological material preservation, potentially exploring automated storage and retrieval systems to further differentiate its market offering. As the firm scales, it will likely seek to deepen its penetration into global research markets, leveraging its established reputation for durability and precision. The strategic focus remains on maintaining competitive pricing while scaling production to meet the rising global demand for life-sustaining biological storage infrastructure.
See full Lutgen Technologies company page
